Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
Key facts
- Who runs it
- University of Birmingham
- Where
- Brazil, India, Mexico, Nigeria, Rwanda, and South Africa38 sites in 6 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 11,668 people enrolled
- Started
- 13 Nov 2020
- Ended
- 30 Sept 2026
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Chlorhexidine mouthwash
- Oxygen
- Record updated
- 16 November 2026
Who can take part
- Age
- 10 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adults and children aged 10 years or over
- Elective or emergency abdominal surgery via midline laparotomy with an anticipated abdominal incision of at least 5cm in length
- Written informed consent of patient (signature or a fingerprint)
Who cannot take part
- Previous enrolment in PENGUIN within the past 30 days
- American Society of Anesthesiologists (ASA) grade V patients (expected to die with or without surgery)
- Patients with a documented or suspected allergy to chlorhexidine
- Patients undergoing caesarean section
- Patient unable to complete postoperative follow-up (not contactable after discharge)
This trial has no sites in United States.
It has sites in 6 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
PENGUIN is a pragmatic multi-center trial investigating the effects of pre-operative mouthwash and perioperative oxygen on the incidences of pneumonia and surgical site infection (SSI) following major abdominal surgery.
Read full original descriptionShow less
Patients will be recruited from low and middle income countries and randomly assigned to a trial treatment arms: a) pre-operative chlorhexidine mouthwash and 80-100% FiO2; b) no pre-operative mouthwash and 80-100% fraction of inspired oxygen (FiO2); c) pre-operative chlorhexidine mouthwash and 21- 30% FiO2; or d) no pre-operative mouthwash and 21-30% FiO2.
The 4 groups in the trial
- Mouthwash and liberal oxygen during surgeryTreatment being tested
Pre-surgical mouthwash with 0.2% chlorhexidine gluconate in combination with 80-100% FiO2 during surgery.
Treatment: Chlorhexidine mouthwash and Oxygen
- No mouthwash and liberal oxygen during surgeryExisting treatment, for comparison
No pre-surgical mouthwash in combination with 80-100% FiO2 during surgery.
Treatment: Oxygen
- Mouthwash and restrictive oxygen during surgeryTreatment being tested
Pre-surgical mouthwash with 0.2% chlorhexidine gluconate in combination with 21-30% FiO2 during surgery.
Treatment: Chlorhexidine mouthwash and Oxygen
- No mouthwash and restrictive oxygen during surgeryExisting treatment, for comparison
No pre-surgical mouthwash in combination with 21-30% FiO2 during surgery.
Treatment: Oxygen
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- PErioperative Respiratory Care and Outcomes for patieNts Undergoing hIgh Risk abdomiNal Surgery: A 2x2 Factorial, International Pragmatic Randomised Controlled Trial Across Low and Middle-income Countries
- Publications
- Record updated
- 16 November 2026